
Thursday, May 20, 2021 2:48:45 PM
The product in their website requires approvals from the FDA but it is not held to the same standards as a Drug. That's why it is being marketed as a Nutraceutical instead of a pharmaceutical (which is what ITV-1 is going through approvals for). Those are the basic main differences.
As far as I know the Rosetta Life Care Bulgaria company is not publicly traded.
--------------
It is connected to ENZC through the 110,000,000 shares owned by its partners as well as the NDI 1083 from the FDA being the main ingredient (which is an Enzolytics NDI) and the Zhabilov Patent.
Additionally a quarterly report put out by ENZC has this to say:
"On July 31, 2018 the Company entered into a license agreement to purchase the worldwide exclusive license for the immunotherapy treatment for Leukemia, the Intellectual Property for the Immune enhancement Nutraceutical Spray used as an immune system infusion, and the intellectual property for the immunotherapy treatment for Multiple Sclerosis owned by The Zhabilov Trust."
Which can be found at the following link: (https://backend.otcmarkets.com/otcapi/company/financial-report/260660/content)
Volume: | 1,102,971 |
Day Range: | 0.0006 - 0.00075 |
Bid: | 0.0006 |
Ask: | 0.0007 |
Last Trade Time: | 3:31:34 PM EDT |
Total Trades: | 20 |
NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market • ELAB • Mar 27, 2025 11:20 AM
LaFleur Minerals Announces Memorandum of Understanding with Granada Gold on Milling Assessment for the Granada Gold Project Using the Beacon Gold Mill • LFLRF • Mar 27, 2025 8:40 AM
Nightfood Holdings (NGTF) Issues Shareholder Update on Imminent Strategic Acquisitions and Rapid Expansion in AI-Powered Hospitality Automation • NGTF • Mar 27, 2025 8:30 AM
ConnectM Secures Landmark Home and Building Electrification Project in India, Marking Strategic International Expansion • CNTM • Mar 27, 2025 7:05 AM
$SYNX - Could Silynxcom Be the Next 1000% Israeli Defense Tech Rocketship? (NYSE: SYNX) • SYNX • Mar 26, 2025 12:15 PM
ConnectM Issues Stockholder Letter from CEO & Chairman • CNTM • Mar 26, 2025 12:14 PM